menu
    • menu

    Company profile for Gan & Lee Pharmaceuticals

    NEW Drugs in Dev: 15
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 1998, Gan & Lee Pharmaceuticals is a high-tech biopharmaceutical company specialized in research, development, production and commercialization of insulin and its analogues, leading in the diabetes market in China. Since its inauguration, Gan & Lee has been focusing on insulin production. In 1998, Gan & Lee successfully developed the first domestic biosynthetic human insulin, which was evaluated as China’s top 10...
    Founded in 1998, Gan & Lee Pharmaceuticals is a high-tech biopharmaceutical company specialized in research, development, production and commercialization of insulin and its analogues, leading in the diabetes market in China. Since its inauguration, Gan & Lee has been focusing on insulin production. In 1998, Gan & Lee successfully developed the first domestic biosynthetic human insulin, which was evaluated as China’s top 10 scientific and technological breakthroughs by Chinese Academy of Sciences and Engineering. Hitherto Gan & Lee has launched multiple biosimilar insulin analogue products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Gan & Lee PharmaceuticalsChina Flag
    Country
    Country
    China
    Address
    Address
    No.8 Nanfeng West 1st Street, Huoxian, Tongzhou District, Beijing 101109
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ganlee.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/gan-&-lee-pharmaceuticals/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gan & Lee Licenses Bofanglutide Globally to JW Pharma
    Gan & Lee Licenses Bofanglutide Globally to JW Pharma

    09 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gan--lee-pharmaceuticals-signs-exclusive-license-agreement-with-jw-pharmaceutical-the-leading-south-korean-pharma-to-advance-the-global-commercialization-of-the-innovative-glp-1-receptor-agonist-bofanglutide-302738066.html

    PR NEWSWIRE
    09 Apr 2026
    Share Share
    Gan & Lee's Once-Weekly GZR4 Insulin Meets Phase 3 Endpoints
    Gan & Lee's Once-Weekly GZR4 Insulin Meets Phase 3 Endpoints

    31 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gan--lee-pharmaceuticals-once-weekly-basal-insulin-gzr4-injection-meets-primary-endpoints-in-two-pivotal-phase-3-clinical-trials-super-1-and-super-2-302730104.html

    PR NEWSWIRE
    31 Mar 2026
    Share Share
    Lupin and Gan & Lee Pharma Enter Exclusive Licensing Deal
    Lupin and Gan & Lee Pharma Enter Exclusive Licensing Deal

    29 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/lupin-and-gan-lee-enter-exclusive-licensing-deal-for-novel-glp-1-receptor-agonist-18712

    INDPHARMAPOST
    29 Dec 2025
    Share Share
    Gan & Lee Starts Ph 3 Trial For 1st Chinese Monthly GLP-1 RA
    Gan & Lee Starts Ph 3 Trial For 1st Chinese Monthly GLP-1 RA

    27 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/once-monthly-glp-1-ra--gan--lee-pharmaceuticals-initiates-phase-3-clinical-study-gradual-3-of-the-first-chinese-once-monthly-glp-1-ra-for-weight-management-302627433.html

    PR NEWSWIRE
    27 Nov 2025
    Share Share
    Gan & Lee Pharmaceuticals' Diabetes Therapies at ADA
    Gan & Lee Pharmaceuticals' Diabetes Therapies at ADA

    22 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gan--lee-pharmaceuticals-presented-multiple-results-in-novel-diabetes-therapies-at-the-american-diabetes-associations-85th-scientific-sessions-302487629.html

    PR NEWSWIRE
    22 Jun 2025
    Share Share
    Gan & Lee Pharma: First Participant Dosed in US Study for Obesity
    Gan & Lee Pharma: First Participant Dosed in US Study for Obesity

    10 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gan--lee-pharmaceuticals-announced-first-participant-dosed-in-the-us-phase-2-clinical-study-of-bofanglutide-gzr18-injection-for-overweight-or-obesity-302397190.html

    PR NEWSWIRE
    10 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search